Results show substantially lower risk of severe illness with an antibody treatment compared with an antiviral, but no benefit found for common heart drugs
Two studies published by The BMJ today provide up to date evidence on the effectiveness of both currently licensed and possible covid-19 treatments under everyday (‘real world’) conditions, helping to shed more light on whether these drugs can prevent people from becoming seriously ill.
Entire content available on: https://www.bmj.com/company/newsroom/studies-provide-latest-real-world-evidence-on-effectiveness-of-covid-19-treatments/
Language
EnglishTypology
News and updatesTopic
Clinical Management Covid-19Target
Public HealthCountries
USA Canada South America Central America Caribbean Middle East South pacific China India Indochina Singapore Europe & UK Oceania Africa